| scholarly article | Q13442814 |
| P50 | author | Greg N. Fuller | Q37370656 |
| P2093 | author name string | Wei Qiao | |
| Raymond Sawaya | |||
| Ganesh Rao | |||
| Waldemar Priebe | |||
| Jun Wei | |||
| Amy B Heimberger | |||
| Ling-Yuan Kong | |||
| Tiffany Doucette | |||
| Adam S Wu | |||
| P2860 | cites work | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies | Q29614311 | ||
| Mouse models of brain tumors and their applications in preclinical trials | Q31062292 | ||
| p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation | Q33733341 | ||
| IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways | Q33888307 | ||
| STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma | Q33903747 | ||
| Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? | Q33921803 | ||
| Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis | Q33951212 | ||
| Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 | ||
| Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. | Q34117204 | ||
| Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway | Q34129168 | ||
| Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas | Q34191508 | ||
| Immune therapeutic targeting of glioma cancer stem cells | Q34676437 | ||
| Glioma cancer stem cells induce immunosuppressive macrophages/microglia | Q34992518 | ||
| A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. | Q55467677 | ||
| Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis. | Q55467774 | ||
| Raising the bar for cancer therapy models | Q84370931 | ||
| PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
| STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells | Q35343534 | ||
| The origin and function of tumor-associated macrophages | Q35352864 | ||
| Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 | ||
| Insulin-like growth factor binding protein 2 promotes glioma development and progression | Q35880328 | ||
| The mighty mouse: genetically engineered mouse models in cancer drug development | Q36568461 | ||
| A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo | Q36647747 | ||
| Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. | Q36691086 | ||
| A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells | Q36973832 | ||
| The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. | Q37020840 | ||
| Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment | Q37169987 | ||
| A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells | Q37172697 | ||
| Genetically engineered mouse models of brain cancer and the promise of preclinical testing | Q37348716 | ||
| IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas | Q37377386 | ||
| Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells | Q37417836 | ||
| Nuclear factor-kappaB and tumor-associated macrophages | Q37681941 | ||
| Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells | Q38323614 | ||
| Foxp3 expression in human cancer cells. | Q38524958 | ||
| Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinoma | Q39671902 | ||
| Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development | Q39869700 | ||
| Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma. | Q39900482 | ||
| Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. | Q39972447 | ||
| Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity | Q40351340 | ||
| STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells | Q40392636 | ||
| Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cyt | Q40795750 | ||
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 | ||
| JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone | Q41257658 | ||
| MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo | Q41661510 | ||
| The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses | Q41779891 | ||
| Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth | Q41893732 | ||
| IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo | Q42139164 | ||
| Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity | Q42801916 | ||
| Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models | Q43056152 | ||
| Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma | Q44414430 | ||
| Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells | Q46750800 | ||
| WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells | Q46868533 | ||
| Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice | Q48148081 | ||
| The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. | Q48369087 | ||
| Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors | Q48445033 | ||
| Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. | Q48476506 | ||
| Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. | Q48973528 | ||
| Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. | Q55465615 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| immunosuppression | Q1455316 | ||
| murine model | Q122890741 | ||
| P304 | page(s) | 5722-5733 | |
| P577 | publication date | 2010-10-04 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses | |
| P478 | volume | 16 |
| Q37612098 | A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients |
| Q35829972 | Cancer stem cells in glioblastoma |
| Q47851037 | Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. |
| Q38851464 | Developing immunotherapeutic strategies to target brain tumors |
| Q36545074 | Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma. |
| Q34736639 | Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma |
| Q36328555 | Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. |
| Q44310747 | Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. |
| Q38868808 | Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype |
| Q24631473 | Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype |
| Q38830051 | HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism |
| Q37435455 | Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas |
| Q38161367 | Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines |
| Q36684162 | Immunologic privilege in the central nervous system and the blood-brain barrier |
| Q98467261 | Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy |
| Q34032023 | Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. |
| Q35166319 | Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model |
| Q36862759 | Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma |
| Q42259199 | Mutant IDH1 regulates the tumor-associated immune system in gliomas |
| Q26830388 | NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age |
| Q37078999 | Prioritization schema for immunotherapy clinical trials in glioblastoma |
| Q35696343 | Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia |
| Q36179166 | Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma |
| Q55456739 | The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. |
| Q26851645 | The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond |
| Q38363102 | The role of STAT3 in tumor-mediated immune suppression |
| Q92105680 | The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells |
| Q39521993 | The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies |
| Q35871559 | The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. |
| Q42577764 | Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression |
| Q38509280 | Type I interferons in anticancer immunity |
| Q37191655 | miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma |
| Q42563520 | miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma |
Search more.